Literature DB >> 23774226

Metabolomics and incident hypertension among blacks: the atherosclerosis risk in communities study.

Yan Zheng1, Bing Yu, Danny Alexander, Thomas H Mosley, Gerardo Heiss, Jennifer A Nettleton, Eric Boerwinkle.   

Abstract

Development of hypertension is influenced by genes, environmental effects, and their interactions, and the human metabolome is a measurable manifestation of gene-environment interaction. We explored the metabolomic antecedents of developing incident hypertension in a sample of blacks, a population with a high prevalence of hypertension and its comorbidities. We examined 896 black normotensives (565 women; aged, 45-64 years) from the Atherosclerosis Risk in Communities study, whose metabolome was measured in serum collected at the baseline examination and analyzed by high-throughput methods. The analyses presented here focus on 204 stably measured metabolites during a period of 4 to 6 weeks. Weibull parametric models considering interval censored data were used to assess the hazard ratio for incident hypertension. We used a modified Bonferroni correction accounting for the correlations among metabolites to define a threshold for statistical significance (P<3.9 × 10(-4)). During 10 years of follow-up, 38% of baseline normotensives developed hypertension (n=344). With adjustment for traditional risk factors and estimated glomerular filtration rate, each +1SD difference in baseline 4-hydroxyhippurate, a product of gut microbial fermentation, was associated with 17% higher risk of hypertension (P=2.5 × 10(-4)), which remained significant after adjusting for both baseline systolic and diastolic blood pressure (P=3.8 × 10(-4)). After principal component analyses, a sex steroids pattern was significantly associated with risk of incident hypertension (highest versus lowest quintile hazard ratio, 1.72; 95% confidence interval, 1.05-2.82; P for trend, 0.03), and stratified analyses suggested that this association was consistent in both sexes. Metabolomic analyses identify novel pathways in the pathogenesis of hypertension.

Entities:  

Keywords:  blacks; hypertension; metabolomics; risk factors

Mesh:

Year:  2013        PMID: 23774226      PMCID: PMC3789066          DOI: 10.1161/HYPERTENSIONAHA.113.01166

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2012-03-23       Impact factor: 5.223

3.  Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women.

Authors:  Esther M Brooks-Asplund; Carrie E Tupper; Jane M Daun; W Larry Kenney; Joseph G Cannon
Journal:  Cytokine       Date:  2002-08-21       Impact factor: 3.861

Review 4.  Sex steroids and insulin resistance.

Authors:  Callum Livingstone; Mary Collison
Journal:  Clin Sci (Lond)       Date:  2002-02       Impact factor: 6.124

Review 5.  Autonomic reactivity and hypertension in blacks: a review and proposed model.

Authors:  N B Anderson; M McNeilly; H Myers
Journal:  Ethn Dis       Date:  1991       Impact factor: 1.847

6.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

7.  Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Lu Wang; Moyses Szklo; Aaron R Folsom; Nancy R Cook; Susan M Gapstur; Pamela Ouyang
Journal:  Atherosclerosis       Date:  2012-07-20       Impact factor: 5.162

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

10.  Validity of the modified Baecke questionnaire: comparison with energy expenditure according to the doubly labeled water method.

Authors:  Emmy M Hertogh; Evelyn M Monninkhof; Evert G Schouten; Petra Hm Peeters; Albertine J Schuit
Journal:  Int J Behav Nutr Phys Act       Date:  2008-05-27       Impact factor: 6.457

View more
  42 in total

1.  Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.

Authors:  Lining Guo; Michael V Milburn; John A Ryals; Shaun C Lonergan; Matthew W Mitchell; Jacob E Wulff; Danny C Alexander; Anne M Evans; Brandi Bridgewater; Luke Miller; Manuel L Gonzalez-Garay; C Thomas Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

2.  Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Zheng; Bing Yu; Danny Alexander; Lyn M Steffen; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Am J Clin Nutr       Date:  2014-04-23       Impact factor: 7.045

Review 3.  Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists.

Authors:  Eline H van Roekel; Erikka Loftfield; Rachel S Kelly; Oana A Zeleznik; Krista A Zanetti
Journal:  Metabolomics       Date:  2019-01-07       Impact factor: 4.290

4.  Serum metabolites associate with lipid phenotypes among Bogalusa Heart Study participants.

Authors:  Xiaoying Gu; Changwei Li; Jiang He; Shengxu Li; Lydia A Bazzano; Jason M Kinchen; Wei Chen; Hua He; Dongfeng Gu; Tanika N Kelly
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-01-21       Impact factor: 4.222

Review 5.  Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP Study: an overview.

Authors:  Queenie Chan; Ruey Leng Loo; Timothy M D Ebbels; Linda Van Horn; Martha L Daviglus; Jeremiah Stamler; Jeremy K Nicholson; Elaine Holmes; Paul Elliott
Journal:  Hypertens Res       Date:  2016-12-22       Impact factor: 3.872

Review 6.  Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.

Authors:  Susan Cheng; Svati H Shah; Elizabeth J Corwin; Oliver Fiehn; Robert L Fitzgerald; Robert E Gerszten; Thomas Illig; Eugene P Rhee; Pothur R Srinivas; Thomas J Wang; Mohit Jain
Journal:  Circ Cardiovasc Genet       Date:  2017-04

7.  Novel associations between blood metabolites and kidney function among Bogalusa Heart Study and Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Jovia L Nierenberg; Jiang He; Changwei Li; Xiaoying Gu; Mengyao Shi; Alexander C Razavi; Xuenan Mi; Shengxu Li; Lydia A Bazzano; Amanda H Anderson; Hua He; Wei Chen; Jason M Kinchen; Casey M Rebholz; Josef Coresh; Andrew S Levey; Lesley A Inker; Michael Shlipak; Tanika N Kelly
Journal:  Metabolomics       Date:  2019-11-13       Impact factor: 4.290

Review 8.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

9.  Associations Between the Serum Metabolome and All-Cause Mortality Among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Bing Yu; Gerardo Heiss; Danny Alexander; Morgan E Grams; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2016-03-07       Impact factor: 4.897

10.  Serum metabolomic profiling and incident CKD among African Americans.

Authors:  Bing Yu; Yan Zheng; Jennifer A Nettleton; Danny Alexander; Josef Coresh; Eric Boerwinkle
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.